Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose colchicine for left ventricular hypertrophy in coronary artery disease
TCTR20210721003Phase 3Unknown
- Sponsor
- National Research Council of Thailand
- Start
- Aug 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in coronary arteriosclerosis, left ventricular hypertrophy (LVH), sponsored by National Research Council of Thailand. Status: unknown.
02
Drugs
colchicine
03
Conditions
coronary arteriosclerosisleft ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on TCTR20210721003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210721003.